title: Embolotherapy in the management of hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) ranks fifth in frequency of cancers worldwide. The incidence of HCC in the United States is rising, primarily due to the number of patients who were infected by hepatitis in the 1960s and 1970s coupled with the rising migrant population from Asia, where hepatitis is widely prevalent. Up to 80% of the patients present with multicentric HCC and advanced liver disease or comorbidities that restrict the option of resection or liver transplantation. The dual blood supply (arterial and portal) to the liver with predominantly arterial supply to the tumor has made embolotherapy a cornerstone in the management of inoperable HCC. The techniques have become refined not only due to the development of microcatheter angiographic capabilities, but also in the ability to deliver a wide variety of therapeutic agents to these tumors. This article reviews the fundamental principles of bland embolization, chemoembolization, and radioembolization in the management of HCC.
authors.affiliation: Department of Radiology, Section of Interventional Radiology, University of Washington School of Medicine, Seattle, Washington.
authors.forename: Alireza
authors.initials: A
authors.lastname: Mojtahedi
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Yang
authors.forename: Gaurav K
authors.initials: GK
authors.lastname: Goswami